Supplying for the Biologics Boom

Supplying for the Biologics Boom

The rising use of biosimilars  is expected to result in the near doubling of the size of pharma cold chain logistics business over the next three years. Pharma IQ spoke with Javier Gomez-Contreras Supply Chain BGx LATAM of GSK about the prospects for vaccine distribution as the industry serves the rise in demand.

Download this piece to learn more about:

  • How cold chain processes have to be adapted when transporting vaccines
  •  What the biggest challenges for the future of vaccine distribution are
  • Which new technologies can support how these vaccines are transported


Please note: That all fields marked with an asterisk (*) are required.